Tina Varghese

Tina Varghese practices at Piedmont Heart Institute in Atlanta, Georgia.

Tina Varghese's NPI, 1780002725, was assigned on April 6, 2014. Tina Varghese holds Georgia license 77579.

Tina Varghese's primary practice is Piedmont Heart Institute, at 275 Collier NW Rd, Atlanta, GA 30309 in Fulton County. The practice phone is (404) 605-2800.

Tina Varghese's primary practice is Piedmont Heart Institute in Atlanta, Georgia. Tina Varghese is also affiliated with Piedmont Atlanta. The medical group on file is Piedmont Heart Institute. Dmand AI also links Tina Varghese to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Tina Varghese practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Tina Varghese's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Tina Varghese is licensed in Georgia.

CMS data shows 1,787 Medicare services from Tina Varghese across 32 procedure codes in 2024, for 1,090 Medicare patients. Medicare paid $82,134 for them.

CMS counts 1,090 Medicare patients who saw Tina Varghese in 2024. The largest group is 75 to 84, with 434 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Tina Varghese's median patient age at 65, with 56% women.

In 2024, Tina Varghese wrote 1,680 Medicare Part D claims for 327 patients. 89% of them were for generic drugs. CMS names the drug for 1,471 of them, across 25 drugs with 11 or more claims each, at $185,831 in total drug cost. In 2023, CMS named 1,196 claims across 21 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Tina Varghese for performance year 2024, reported through an alternative payment model (APM). Tina Varghese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Tina Varghese as offering telehealth.

Dmand AI links 10 papers to Tina Varghese, published from 2016 to 2025. 2017 was the busiest year, with 3. The most frequent topics are Exercise, Primary Prevention and Risk Reduction Behavior. Tina Varghese has published most often in Curr Pharm Des. Tina Varghese's most frequent co-authors are Laurence S. Sperling, MD, Devinder Singh Dhindsa and Danny John Eapen, MD.

CMS Open Payments shows 47 general payments to Tina Varghese from 11 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $484.